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We have designed a DNA cassette to transcribe defective interfering (DI) RNAs of tomato bushy stunt virus
(TBSV) and have investigated their potential to protect transgenic Nicotiana benthamiana plants from tombusvirus infections. To produce RNAs with authentic 5* and 3* termini identical to those of the native B10 DI
RNA, the DI RNA sequences were flanked by ribozymes (RzDI). When RzDI RNAs transcribed in vitro were
mixed with parental TBSV transcripts and inoculated into protoplasts or plants, they became amplified,
reduced the accumulation of the parental RNA, and mediated attenuation of the lethal syndrome characteristic
of TBSV infections. Analysis of F1 and F2 RzDI transformants indicated that uninfected plants expressed the
DI RNAs in low abundance, but these RNAs were amplified to very high levels during TBSV infection. By two
weeks postinoculation with TBSV, all untransformed N. benthamiana plants and transformed negative controls
died. Although infection of transgenic RzDI plants initially induced moderate to severe symptoms, these plants
subsequently recovered, flowered, and set seed. Plants from the same transgenic lines also exhibited broadspectrum protection against related tombusviruses but remained susceptible to a distantly related tombus-like
virus and to unrelated viruses.
of reports of their association with plant viruses (19). DI RNAs
associated with tomato bushy stunt virus (TBSV) were the first
of this type of symptom-modulating RNA to be definitively
characterized in plants (22).
TBSV has a positive-sense RNA genome of ;4.8 kb (Fig.
1A) that encodes five proteins (21). These proteins include
replicase proteins p92 and p33 (53), the capsid protein p41
(23), the cell-to-cell movement protein p22, and a nested p19
gene, which functions in systemic invasion in some hosts and
which is also involved in eliciting necrosis (49, 50). A sixth
gene, pX, contains RNA sequences that have an undefined
host-dependent effect on pathogenesis (47), but a direct role
for the predicted product has not been identified. TBSV generates DI RNAs reproducibly during high-multiplicity passage
experiments (27), and the evolution of tombusvirus DI RNAs
likely involves a series of stepwise deletions of various segments of the viral genome (58, 59).
Sequence analyses have revealed that tombusvirus DI RNAs
vary in size, but they all contain four conserved regions that
contain cis elements required for replication (5, 22, 27). The
prototypical B10 DI RNA (27) used in this study is 595 nucleotides (nt) long and consists of motifs derived from the 59
untranslated region (region I), the polymerase gene (region
II), and two segments of sequence (regions III and IV) located
at the 39-proximal portion of the viral genome (Fig. 1A). Previous results have demonstrated that coinoculations of TBSV
and B10 DI RNAs produce a dramatic attenuation in the
development of symptoms in plants (27). The B10 DI RNA has
also been shown to inhibit accumulation of viral RNAs in
protoplasts (25), as well as contribute to a reduction in viral
RNA and protein accumulation in plants (52). A previous
study (28) suggested that a DI RNA from a related virus,
cymbidium ringspot virus (CymRSV), may have the potential
to attenuate disease development. The results described here
demonstrate that TBSV DI RNAs protect against the lethal

Several types of pathogen-derived resistance (PDR) are
known to occur in transgenic plants expressing viral genes. The
coat protein gene of tobacco mosaic virus (TMV) was the first
viral gene used to produce PDR in transgenic plants (37), and
subsequently coat protein-mediated protection has been the
most frequently attempted approach to obtain PDR (2, 32). In
addition to resistance attributed to expression of coat protein
genes in transgenic plants, a variety of other viral sequences,
including replicase or movement genes, or mutated nonfunctional derivatives of these genes have been shown to provide
synthetic resistance (1, 2, 32, 51, 60). Transgenic plants harboring different elements often vary substantially in the level
and type of PDR observed, suggesting that fundamentally different cellular mechanisms that affect virus replication may be
involved in the protective effects (8, 12–15, 18, 33, 38, 54, 61).
In addition to portions of viral genomes, complete sequences of defective interfering (DI) RNAs (28, 55) and satellite RNAs (17, 20) have also been used to engineer resistance
in transgenic plants. DI RNAs are subviral deletion mutants
consisting of portions of the parental virus genome that
through rearrangements, deletions, or recombination events
have evolved to smaller derivatives. These defective molecules
lack functions essential for autonomous replication, so they
must depend upon the parental helper virus for these functions
(24). This dependence reinforces effective competition with
the parental virus for trans-acting factors required for replication. Consequently, many DI RNAs interfere drastically with
virus accumulation and attenuate the disease phenotype elicited by the helper virus. DI RNAs are thought to occur almost
universally in animal viruses, and there are increasing numbers
* Corresponding author. Mailing address: Department of Plant and
Microbial Biology, 111 Koshland Hall, University of California, Berkeley, CA 94720. Phone: (510) 642-3906. Fax: (510) 642-9017. E-mail:
andyoj@uclink4.berkeley.edu.
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necrosis elicited by TBSV in Nicotiana benthamiana and that
transgenic plants expressing TBSV DI RNAs have considerable promise for broad-spectrum control of tombusviruses.
MATERIALS AND METHODS
Plasmid constructs. Clones of different tombusviruses suitable for in vitro
production of infectious cDNA-derived transcripts have been described previously. These clones include pTBSV-100 (21), pTBSV-B10 (27), pCNV (pK2/M5)
(40), pCymRSV (G11) (9), pCIRV (43), and pCLSV (36). In control experiments, we have also used a potato virus X (PVX) cDNA plasmid (6), which
contains unique cloning sites engineered downstream of the duplicated coat
protein subgenomic promoter, and a PVX construct (pHS-142) containing the
p19 gene of TBSV (49).
In order to generate DI transcripts with precise 59 and 39 termini, the B10 DI
RNA sequence was flanked by ribozymes (RzDI). A modified tobacco ringspot
satellite virus (TRSV) ribozyme fusion was generated to provide a precise 39 end
(39), and an avocado sunblotch viroid (ASBVd) ribozyme was engineered for
cleavage at the exact 59 end of the DI RNA (10). To engineer the ribozyme
sequences at the ends of the DI RNA, two rounds of PCR were performed with
pTBSV B10 DI RNA as a template. The first set of reactions used the oligonucleotide Rz59-1 (59 GAGGACGAAA CCCTTTGGGG TCGAAATTCT CCA
GGATTTC 39), which contains the first 17 nt of the 59 end of the B10 DI RNA
and 23 nt of the 39 end of the ASBVd ribozyme, and the oligonucleotide Rz39 (59
GAGCTCACCA GGTAATATAC CACAACGTGT GTTTCTCTGG TAGCC
TTCTC TGTCATACGG ACAGGACGGG CTGCATTTTC TGC 39), which
contains the last 16 nt of the DI RNA sequence followed by 67 nt derived from
the TRSV ribozyme. A second round of PCR was used to add the remaining 59
segment of the ASBVd ribozyme by using a 59 oligonucleotide Rz59-2 (59 CCC
CCTCGAG AATTTCCTGA TGAGTCCGTG AGGACGAAAC CCTTTG 39)
and the 39-end Rz39 oligonucleotide. The PCR product containing the DI RNA
sequence flanked by the two ribozymes was cloned into the EcoRV site of
pBS-SK(2) (Stratagene, La Jolla, Calif.) to place the 59 end of the DI RNA
under the control of the bacteriophage T7 promoter. This resulting transcription
plasmid was designated pSK-RzDI. Subsequently, the DI RNA flanked by the
two ribozyme sequences was excised with XhoI and SacI restriction enzymes and
cloned into the XhoI and SacI sites of pKYLX71-35S2, a version of the plant
expression vector pKYLX7 (46) with a double 35S promoter and a nos terminator. This plasmid was designated pKL-RzDI.
Two other constructs were created for use as negative controls. One plasmid
designated pKL-ASDI contained an antisense DI RNA flanked by nonprocessing
sequences complementary to the two ribozymes. This plasmid was produced by
cloning the SmaI/XhoI fragment from pSK-RzDI into pKYLX7-35S2. For this
purpose, pKYLX7-35S2 was digested with HindIII and treated with Klenow
fragment (New England Biolabs, Beverly, Mass.) to fill in the overhanging sequences and then digested with XhoI. The other control plasmid, pKL-ESDI,
containing the pTBSV-B10 sequence flanked by extra sequences from pBS-SK1,
was produced by first cleaving pTBSV-B10 with ApaI and HindIII and subsequently cloning it into the corresponding sites of pBS-SK1 (Stratagene). Then,
the DI RNA and the extra flanking sequences were digested with KpnI, blunt
ended with T4 DNA polymerase (New England Biolabs), digested with SacI, and
cloned between the HindIII-digested, Klenow fragment-treated site and the SacI
site of pKYLX7-35S2. This manipulation produced transcripts with 23 nt from
pBS-SK1 abutting the 59 end of the B10 DI RNA and 73 nt at the 39 end. The
T-DNAs of pKL-RzDI, pKL-AS, and pKL-ES were introduced into N. benthamiana by Agrobacterium tumefaciens (strain LBA4404) transformation (41), and
transformed lines were regenerated from leaf discs in the presence of 50 mg of
kanamycin sulfate per ml.
In vitro transcription reactions and plant infections. The pTBSV, pCNV,
pCymRSV, pCIRV, and pTBSV-B10 plasmids were linearized with SmaI (21),
and PVX and pHS-142 were linearized with SpeI (49). The linearized plasmids
were then treated with T4 DNA polymerase, and in vitro transcripts were produced by bacteriophage T7 RNA polymerase (21) and in the case of the PVX
construct in the presence of capping analog. Positive-sense DI-ribozyme transcripts from the plasmid pSK-RzDI were generated by T7 RNA polymerase and
the negative-sense DI RNAs were transcribed by T3 RNA polymerase (New
England Biolabs). These in vitro transcripts were used to coinoculate plants or
protoplasts with TBSV transcripts (25). TMV (11) and belladonna mottle virus
(BDMV) (30) were maintained in N. benthamiana plants. Sap from these plants
was used as inoculum to infect RzDI transgenic plants.
To evaluate ribozyme processing, pSK-RzDI was linearized with SmaI, and in
vitro transcripts were produced by the T7 RNA polymerase in the presence of
32
[ P]UTP. Then, the reactions were terminated at 0.5, 1, 2, and 4 h by freezing
in dry ice and the reaction mixtures were subsequently analyzed in 5% polyacrylamide gels containing 8 M urea.
Nucleic acid and protein analyses. RNA extracted from plants (57) and protoplasts (25) was separated in formaldehyde gels or in 13 TBE (Tris-borateEDTA) nondenaturing gels. The RNAs were then blotted and hybridized with a
32
P-labeled DNA probe corresponding to the 39-terminal 245 nt of TBSV RNA.
Reverse transcription-PCR (RT-PCR) analyses using RNA from noninfected
transgenic plants were conducted with 5 mg of total RNA from different trans-
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genic lines. The oligonucleotides 59TBSV (59 GAAATTCTCC AGGATTTCTC
G 39) and 39TBSV (59 GGGCTGCATT TCTGCAATG 39) were added to the
reaction mixtures to amplify the DI RNA sequences. A second primer pair,
59Rz2 (59 CCCCCTCGAG AATTTCCTGA TGAGTCCGTG AGGACGA
AAC CCTTTG 39) and 39Rz2 (59 ACGTGTGTTT CTCTGGTAGC C 39), were
used to test whether DI RNA sequences flanked by ribozymes could be amplified. After 30 amplification cycles, the products were electrophoresed on a 13
TBE gel, blotted, and hybridized with a 32P-labeled DNA probe corresponding
to the DI RNA sequence. RT-PCR analysis using RNA from infected transgenic
plants with the different tombusviruses was performed with 5 mg of total RNA
and the four oligonucleotide pairs: 59TBSV-39TBSV, 59Rz2-39Rz2, 59TBSV39Rz2, and 59Rz2-39TBSV. The amplified products were subcloned into the TA
cloning vector (Invitrogen, Carlsbad, Calif.) and subjected to sequence analyses
by using double-stranded plasmid DNA (45) and Sequenase (U.S. Biochemicals,
Cleveland, Ohio). Some sequencing reactions used the ABI PRISM BigDye
Terminator Cycle Sequencing Ready Reaction Kit (PE Applied Biosystem, Foster City, Calif.). In these cases, the analyses were performed on an ABI 377
automated DNA sequencer at the Iowa State University DNA Sequencing Facility. Protein recovered from tissue was analyzed by polyacrylamide gel electrophoresis and immunoblotting (Western blotting) as described previously (50).
DNA extractions from transgenic and nontransformed controls were performed
with a DNeasy plant minikit (Qiagen, Hilden, Germany). PCR amplification of
sequences inserted into the plant genome was performed with primers Rz59-2
and Rz39 or TBSV primers 59TBSV and 39TBSV. Southern hybridizations were
conducted by minor modifications of procedures described previously (45).

RESULTS
Ribozymes flanking DI RNAs produce biologically active
molecules. Initial protoplast experiments revealed that the
ends of the transgenic DI RNAs needed to match the termini
of the native B10 DI RNA closely in order to be recognized
and amplified efficiently by TBSV (data not shown). During
protoplast cotransfections with TBSV transcripts, replication
of DI RNAs with exact 59 termini but with an additional 73 nt
of 39-terminal sequences from pBS-SK1 (Stratagene) was severely compromised, and sequences corresponding to the DI
RNA sequences were difficult to detect by Northern hybridization at 24 h after transfection. Antisense copies of the B10
DI RNA containing 34 extra nt at the 59 end and an additional
77 nt at the 39 end also failed to be amplified by the parental
virus. Surprisingly, antisense RNAs corresponding exactly in
complementary sequence to an equivalent of the B10 DI RNA
also failed to accumulate to detectable levels when cotransfected with TBSV (50a). These results thus suggest that efficient DI RNA amplification requires positive-sense DI RNAs
with precise or nearly precise termini.
In order to create transgenic plants expressing DI RNAs
with sequences identical to those present in the 595-nt precursor B10 DI RNA, we engineered ribozyme sequences at the 59
and the 39 termini (Fig. 1B). The resulting transcription products of these constructs were designated RzDIs. Prior to plant
transformation, the ribozyme sequences were tested for their
ability to process the RzDI to yield synthetic B10 derivatives
capable of replication. To evaluate in vitro processing of the
ribozymes, a time course experiment (0.5, 1, 2, and 4 h) was
performed whereby 32P-radiolabeled transcripts were synthesized in vitro, frozen in dry ice at different times after initiation
of the reactions, and subsequently analyzed in polyacrylamide
gels (Fig. 1C). These experiments indicated that the RzDI
RNA transcripts were processed to liberate two small bands
corresponding to the 59 and 39 ribozyme sequences (46 and 67
nt, respectively), as well as larger bands corresponding to the
unprocessed, intermediate, and cleaved B10 DI RNAs (Fig. 1B
and C).
To assess the biological activity of the DI RNAs, protoplasts
were cotransfected with TBSV transcripts plus mixtures of
ribozyme-flanked transcripts and their reaction products. Although these RzDIs did not reach wild-type B10 DI RNA
accumulation levels, they were amplified to high levels in infected protoplasts and they interfered with replication of the
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FIG. 2. Amplification of DI RNAs in coinoculations with TBSV in protoplasts and attenuation of symptoms in plants. (A) DI RNA accumulation and
inhibition of TBSV replication in transfected N. benthamiana protoplasts. Northern blot analyses of total RNA isolated from protoplasts 18 h posttransfection
with in vitro TBSV transcripts alone (lanes 1 and 4) or in combination with native
B10-DI transcripts (T1B10; lane 2) or pSK-RzDI transcripts (T1RzDI; lane 5)
or mock transfections (lane 3). Each lane corresponds to approximately 105
protoplasts. The blot was probed with a randomly primed 32P-labeled DNA
corresponding to the B10 DI RNA, and the autoradiograph was exposed for 5 h.
The positions of the gRNA, sgRNA1, sgRNA2 are indicated. (B) Effects of DI
RNAs on symptoms in N. benthamiana plants. The plants were mechanically
inoculated with TBSV transcripts, TBSV transcripts mixed with transcripts from
pTBSV-B10 (T1B10), or TBSV and pKS-RzDI RNA transcript mixtures
(T1RzDI), and photographed 2 weeks later. An uninoculated control (Mock) is
shown. Note that the presence of DI RNAs (T1RzDI and T1B10) resulted in
attenuated systemic symptoms, while TBSV alone was lethal to the plants.

FIG. 1. Processing of TBSV B10 DI RNA flanked by ribozymes. (A) A map
of the TBSV genome is illustrated at the top, with the six coding regions (p33,
p92, p41, p22, p19, and pX) identified. The four conserved regions of the 595-nt
B10 DI RNA are represented below the map by blocks (I, II, III, and IV) to
indicate the sequence motifs derived from different regions of the TBSV genome. (B) Schematic illustration of ribozyme processing. The B10 DI RNA was
flanked at its 59 end by the ASBVd ribozyme (59Rz) and at its 39 end by the
TRSV ribozyme (39Rz). Sites of ribozyme cleavage are indicated by small arrows
flanking the DI RNA. Intermediate and final products (B10 DI, 59Rz, and 39Rz)
of the in vitro processing reaction are illustrated. (C) Evaluation of ribozyme
processing in vitro. Time course experiments showing the in vitro processing of
the B10 DI RNA by flanking ribozymes. The positions of the processed and
unprocessed DI RNAs, as well as the locations of the liberated ribozymes (59Rz
and 39Rz), are indicated. The in vitro transcription reactions were performed at
37°C with T7 RNA polymerase in the presence of [32P]UTP, and the samples
were separated on 5% acrylamide gels. Short (4-h) and long (20-h) exposures
were used to permit visualization of the individual bands.

parental TBSV RNAs (Fig. 2A). N. benthamiana plants inoculated with wild-type TBSV transcripts alone developed the
characteristic lethal necrotic syndrome (Fig. 2B) that is consistently associated with TBSV infections (48). This phenotype
was characterized by the appearance of a mild mosaic interspersed with faint yellow flecks within 3 to 4 days postinoculation (dpi) that progressed to necrotic lesions, severe leaf
distortion, and apical necrosis. A rapid vascular collapse that
culminated in death of the plant between 7 to 10 days dpi
subsequently followed (Fig. 2B). However, the symptom severity was greatly diminished by coinoculation of TBSV with tran-

scripts derived from the clones containing the native DI RNA
(B10) or the B10 DI RNA flanked by the ribozymes (RzDI).
These attenuated symptoms consisted of a mild mosaic and
slight stunting, combined with small sporadic chlorotic and
necrotic lesions on the systemically infected leaves (Fig. 2B).
These plants subsequently flowered and produced seed. Thus,
the RzDIs elicited the same protective phenotype in coinfections with TBSV as the native B10 DI RNA.
Transgenic plants accumulate low levels of DI RNAs. The
promising results with inoculation of RzDI transcripts suggested that these molecules might provide useful resistance if
expressed in transgenic plants. RzDI sequences in positive
(RzDI lines) and antisense (AS lines) orientations, as well as a
B10 DI RNA flanked by extra sequences (ES lines), 23 nt at
the 59 end and 73 nt at the 39 end from the plasmid pBS-SK1,
were placed under the control of a double 35S promoter, and
transgenic N. benthamiana plants were obtained via Agrobacterium-mediated leaf disc transformation. F1 and F2 progeny
lines were grown on agar containing kanamycin for selection of
transformed lines. Forty of the RzDI lines, seven AS lines, and
four ES lines were analyzed for resistance and the relative
accumulation of the DI transcripts. In order to determine the
nature of the inserted sequences, we performed PCR amplifications using DI (Fig. 3A) and ribozyme (Fig. 3B) primers with
DNA from 12 selected RzDI transgenic lines (225, 229, 221,
69, 27999, 275, 279, 615, 228, 612, 616, and 611), two AS lines,
and one ES line, each of which contained one or two copies of
the transgene as deduced by Southern hybridization (data not
shown). Control amplifications were also conducted with the
plasmid pTBSV-B10 that contained the B10 DI RNA sequence. Amplifications using the pTBSV-B10 and the DI RNA
primers produced a band which hybridized to a 595-nt probe
encompassing the B10 DI RNA sequence (Fig. 3A and B, lanes
17). Similar-sized bands were amplified from genomic DNA of
the 12 RzDI transgenic plants (Fig. 3A, lanes 2 to 16). Slightly
larger bands corresponding in size to the DI and flanking
ribozyme sequences were amplified by the ribozyme primers
(Fig. 3B, lanes 2 to 16), except for the line ES (Fig. 3B, lane 4),
for which no product was obtained, as predicted. In contrast,
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FIG. 3. DI RNA integration and transcript accumulation in transgenic
plants. (A) Southern blot analyses of PCR performed with genomic DNA using
59TBSV- and 39TBSV-specific primers. Products of 12 RzDI transgenic plant
lines are analyzed in lanes 5 through 16. AS3 (lane 2) and AS8 (lane 3) illustrate
antisense lanes, and ES (lane 4) represents RNA from plants transformed with
the B10 DI RNA flanked by extra plasmid DNA sequences. As a negative
control, DNA was extracted from untransformed N. benthamiana plants (NI;
lane 1), and as a positive control, the PCR amplifications were conducted with
the plasmid pSK-RzDI, which contains the RzDI sequence (DI; lane 17). The
positions of the DI and RzDI products are indicated by arrows at the sides of the
blots to serve as size markers for the amplified plant DNAs. (B) Southern blot as
in panel A, except that the PCR amplifications were conducted with the 59Rz1
and 39Rz primers. The labeling was done as described above for panel A. (C)
Northern blot analysis of RNA from different lines of uninoculated RzDI transgenic plants (noted above each lane). Total RNA (10 mg) extracted from leaves
was electrophoresed in a denaturing 1% formaldehyde–agarose gel. The blot was
probed with 32P-labeled DNA prepared by random priming of a purified 595-nt
fragment encompassing the B10 DI RNA sequence. The arrows indicate the
positions of the DI size markers. (D) TBSV amplification of DI RNA from
transgenic RzDI protoplasts. Protoplasts were isolated from untransformed (N.
benthamiana) and transgenic RzDI lines 221 and 615 and transfected with 2, 5,
or 10 mg of in vitro-transcribed TBSV RNA. Untransformed protoplasts were
also cotransfected with in vitro transcripts from TBSV and the B10 DI (T1DI).
Each lane contains approximately 105 protoplasts. The blot was probed with a
randomly primed 32P-labeled DNA corresponding to the B10 DI RNA. The
positions of the gRNA, sgRNA1, sgRNA2, and DI RNAs are indicated. M,
mock-inoculated protoplasts.

DNA extracted from control untransformed plants did not
contain amplifiable sequences (Fig. 3A and B, lanes 1). These
results suggested that each transformed line contained an intact integrated DI RNA sequence plus the flanking ribozyme
sequences (Fig. 3A and B).
Accumulation of DI RNA transcripts in uninoculated plants
was also estimated by hybridization of total RNA extracted
from the same transgenic lines (Fig. 3C, lanes 2 to 16). As
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expected, no hybridization to the DI probe was observed in
untransformed plants (Fig. 3C, lane 1). Except for line AS8
(lane 3) which had a clearly visible band, hybridizing bands
with mobility corresponding to that of the B10 DI RNA were
also difficult to detect in the other transgenic lines. Lines ES,
279, 612, and 616 appeared to accumulate the highest abundance of sequences with mobilities similar to those of the DI
RNAs. Smaller hybridizing entities were also visible in several
lines, suggesting that the transcribed RNAs were undergoing
some form of degradation (Fig. 3C, lanes 4, 9, 11, 13, and 14).
To further analyze the nature of the DI RNA species expressed in the transgenic plants, we performed RT-PCR analyses on RNA extracted from four transgenic lines using specific
primers to amplify sequences containing or lacking the ribozyme sequences and subsequently subjected the RT-PCR
products to hybridization with a DI cDNA probe. When DI
RNA-specific primers were used (59TBSV primer and 39TBSV
primer) an amplification product was detected in the RzDI
transgenic lines. In contrast, when ribozyme-specific primers
were used (59Rz2 primer and 39Rz2 primer) products were not
amplified from RNA isolated from the RzDI transgenic lines,
and only a single band was visible using RNA from the antisense transgenic line AS3 (data not shown). These results
suggest that the transgenic RzDI RNAs were efficiently processed in vivo by the flanking ribozymes to generate the native
B10 DI RNA.
To assess the amplification of DI RNA in transgenic RzDI
plants, protoplasts were isolated from untransformed and
transgenic RzDI plants (lines 221 and 615) and transfected
with different amounts of TBSV transcripts (2, 5, and 10 mg).
We tested two representative transgenic lines (221 and 615)
that showed evidence of a DI RNA sequence, each of which
had barely detectable levels of constitutive expression of the
RzDI RNA. Upon infection with TBSV, high levels of accumulation of replicating DI RNA were present in line 615,
lower levels were evident in line 221, and hybridizing bands
were not detectable in the untransformed control (Fig. 3D) at
18 h posttransfection. These protoplast results thus demonstrate that the processed RzDI RNAs are biologically active
and can be amplified efficiently by TBSV.
Protection against TBSV disease development in transgenic
plants expressing DI RNAs. Untransformed N. benthamiana
plants inoculated with TBSV developed the typical lethal syndrome consistently observed for TBSV infections in this host.
However, the transgenic plants from the 12 RzDI lines shown
in Fig. 3 exhibited attenuated symptoms that were similar to
those illustrated for transgenic line 615 (Fig. 4A and B). These
symptoms were also typical of those of untransformed plants
following coinoculation with mixtures of the B10 and TBSV
transcripts (Fig. 2B). Subsequently, we evaluated the effects of
inoculum dosage on the degree of symptom attenuation using
in vitro-transcribed TBSV RNA (0.008, 0.04, 0.08, 0.8, 4, and 8
mg/ml), as well as purified virus (0.1 and 1 mg/ml) in transgenic
plants. In these experiments, plants infected with various concentrations of in vitro-transcribed RNA had a pronounced
mosaic at 2 weeks postinoculation (wpi) (Fig. 4A). By 4 wpi,
some plant-to-plant variation was evident, but all plants were
in various stages of recovery from the pronounced symptoms
that appeared in the early stages of infection (Fig. 4B). In
contrast, the antisense (AS3 and AS8) and extra sequence (ES)
N. benthamiana negative-control lines showed no discernible
resistance and died within 2 wpi with TBSV (Fig. 4C). As
expected, TBSV infections of control plants progressed rapidly
into a severe necrosis, followed by a pronounced vascular collapse and plant death (Fig. 4C).
Minor differences in symptom development were observed
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FIG. 4. Resistance to TBSV infection and inhibition of viral replication in
RzDI transgenic plants. In the panels on the left (A, B, and C), different amounts
of TBSV RNA transcripts and viral particles (TBSV) were used to inoculate each
plant. (A) Protected RzDI transgenic plants (line 615) showing a moderate
disease phenotype at 2 wpi with TBSV. (B) RzDI transgenic plants illustrating
the recovery phenotype at 4 wpi with TBSV. These plants eventually flowered
and produced seeds. (C) Nontransformed plants 2 wpi, showing the lethal necrotic syndrome elicited by TBSV. Note that even the plants infected with the
lower concentration of in vitro-transcribed TBSV RNA (8 ng) died by 2 wpi. The
panels on the right (D, E, and F) show Northern blot analyses performed on
RNA extracted from RzDI transgenic lines. (D and E) RNA extracted from line
615 at 2 wpi (D) and at 4 wpi (E) and (F) RNA extracted from different RzDI
transgenic lines (611, 616, 69, 279, 221, and 615) at 6 wpi. Blots were probed with
a specific probe encompassing the 39-terminal 245 nt of the TBSV genome. Note
that lane NbI contains RNA extracted from dying tissue of untransformed N.
benthamiana plants at 2 wpi with TBSV transcripts. The NI lanes in all panels
correspond to RNA extracted from noninfected plants. The positions of the
TBSV gRNA and sgRNAs and the DI RNA are indicated to the right of the
blots.

in different infectivity experiments among the 11 remaining
RzDI lines. The onset of symptoms was usually delayed slightly
in the transgenic plants in comparison to untransformed controls. However, both RzDI and nontransformed plants initially
developed the mosaic symptoms characteristic of TBSV infection, and the control plant infections progressed into the lethal
syndrome. In contrast, plants expressing the RzDIs displayed
moderate disease symptoms between 1 and 2 wpi which included some leaf distortion, curling, small necrotic lesions, and
limited apical necrosis in ;15% of the plants. The disease
symptoms were also generally more severe under warmer
greenhouse conditions exceeding 35°C, but an obvious protective effect was noted in all RzDI transgenic lines (not shown).
Irrespective of the temperature, all of the RzDI plants showed
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signs of recovery from infection by 2 wpi with newly emerging
leaves exhibiting a milder mosaic along the apical and lateral
stems. By 4 to 6 wpi, the infected RzDI plants were slightly
smaller than uninoculated controls and began to develop more
lateral branches (Fig. 4B). Subsequently, the DI transgenic
plants flowered and produced seeds, although curling, mild
chlorosis, and occasional small necrotic spots were still evident
in the leaves.
High levels of DI RNAs accumulate during TBSV infection
of RzDI plants. Leaves from infected RzDI transgenic plants
were collected from 3 dpi to 6 wpi, and RNA analyses were
performed. These analyses revealed that the levels of the DI
RNAs in inoculated plants exceeded those of uninoculated
RzDI transgenic plants as early as 3 dpi, and by 1 wpi, the DI
transcripts and the TBSV genomic RNA (gRNA) and subgenomic RNA (sgRNA) accumulated to very high levels (data
not shown). Northern blots of RNA isolated from RzDI lines
at 2 wpi, which corresponds to the late stages of vascular
collapse and necrosis in untransformed plants, showed a high
abundance of TBSV-specific RNAs, with even greater amplification of the DI RNA (Fig. 4D). However, by 4 wpi, there was
a substantial decrease in the abundance of the TBSV RNAs,
with a concomitant reduction in DI RNAs (Fig. 4E), that
corresponded to the recovery of the transgenic plants (Fig.
4B). By 6 wpi, the TBSV-specific RNAs were reduced to barely
detectable levels in most of the transgenic lines (Fig. 4F). At
this stage of infection, the levels of the DI RNAs were also
reduced but to a lesser extent than the TBSV RNAs. In addition, the levels of accumulation of the TBSV-encoded p33 and
p19 proteins assessed by Western blotting reflected the relative
abundance of the TBSV RNAs (data not shown). Thus, these
experiments demonstrate that amplification of DI RNAs is
highly correlated with the protective effects exhibited in transgenic plants after TBSV infection.
Transgenic DI plants exhibit broad-spectrum protection
against tombusviruses. To evaluate resistance of the RzDI
transgenic lines to different members of the tombusvirus genus, transgenic and untransformed plants were inoculated with
infectious RNA transcripts of the following viruses; TBSV,
cucumber necrosis virus (CNV), CymRSV, and carnation Italian ringspot virus (CIRV). Untransformed plants and negative-control lines (AS3, AS8, and ES) infected with TBSV,
CNV, and CIRV developed lethal syndromes similar to TBSV
(Fig. 5A and B). However, plants infected with CymRSV displayed a less severe disease phenotype, with many plants surviving for 6 wpi. In all cases, the DI transgenic plants exhibited
the attenuated symptoms observed in the typical TBSV infections and exhibited strong protective effects against each of the
viruses tested. In addition, recovery of the plants was evident
by 2 wpi (Fig. 5C). Interestingly, although individual plant lines
appeared to be protected to a similar extent, the time course of
accumulation of different viral RNAs varied substantially at 2
wpi, and some variation was also observed among different
transgenic lines (Fig. 5D, E, and F). For example, the accumulation of gRNA was more pronounced in CNV and CIRV
infections (Fig. 5D and E) than in CymRSV infections (Fig.
5F). There also was a reduced level of DI RNA accumulation
associated with CIRV infections. For reasons that are not
understood, line AS3 (but not line AS8) showed occasional
variable accumulation of the DI RNA after infection with
CymRSV. The most pronounced accumulation noted is shown
in Fig. 5F.
The amplification of the DI transcripts by the related tombusviruses was expected due to the high homology at the nucleotide level among the members of the group. This relatedness is particularly evident within the 59 and 39 untranslated
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FIG. 5. Broad-spectrum protection of RzDI transgenic plants against different tombusviruses. (A) Untransformed plants (Nb) at 2 wpi with TBSV, CNV, CymRSV
(CyRSV), and CIRV. (B) Antisense A3 DI line photographed at 2 wpi. (C) RzDI transgenic line 615 at 2 wpi. The bottom panels show accumulation and amplification
of the DI transcript at 2 wpi of different lines with CNV, CIRV, and CymRSV. Northern blots performed with 10 mg of total RNA extracted from the different lines
at 2 wpi. The designations of the RzDI lines are as given in the legends to Fig. 3 and 4. The negative controls are noninfected untransformed plants (NbI),
untransformed plants infected with each of the different viruses, and AS3, the transgenic line AS3 transformed with an antisense DI RNA. The positions of the gRNAs
and sgRNAs of CNV, CIRV, and CymRSV as well as the amplified TBSV DI RNAs, are indicated. Hybridizations were performed using a randomly primed 32P-labeled
DNA probe encompassing the 39-proximal 245 nt of TBSV RNA.

regions which contain cis-acting elements necessary for replication. In this regard, infections with cucumber leaf spot virus,
a distantly related tombus-like virus, which has a much lower
level of sequence homology at the 59 and 39 termini than other
tombusviruses (36), failed to amplify the TBSV DI RNA after
virus inoculation and the transgenic plants developed the same
disease phenotype as untransformed N. benthamiana controls
(data not shown). These results thus show that sequence specificity affects the ability of various tombusviruses to amplify the
B10 DI RNA, and provide additional evidence that the protective effect requires efficient amplification of the DI RNA
sequences.
To confirm that the DI RNAs amplified by the different
tombusviruses originated from the RzDI transgene, we performed RT-PCR analysis of total RNA isolated from transgenic plants infected with the different tombusviruses and then
sequenced the amplified products. Total RNA was isolated
from transgenic plants infected with TBSV, CNV, CIRV, and
CymRSV, and RT-PCR was performed using DI RNA-specific
primers (59TBSV and 39TBSV), ribozyme-specific primers
(59Rz2 and 39Rz2), or heterologous combinations of these
primers to test for the presence of only one of the ribozymes.
Defined amplification products with each tombusvirus were
evident only when DI RNA-specific primers were used in the
RT-PCRs, and only faint smears were obtained when ribozyme
primers alone or heterologous combinations of TBSV and Rz
primers were used (data not shown). Sequence analysis of the
DI RNA-specific products revealed that in each case the DI
RNA amplified in the transgenic plants by the different tombusviruses was derived from the transgene; these results argue
against the possibility that the DI RNAs originated from the
inoculated virus.
To determine whether the protective effects were restricted
to tombusviruses, the transgenic plants were also infected with
unrelated viruses including TMV (11), BDMV, PVX, and a
PVX clone (pHS-142) containing the sequences of the p19

gene of TBSV whose expression results in the lethal syndrome
in N. benthamiana (49). In challenges with these viruses, RzDI
transgenic plants, the negative controls (A3 and ES plants),
and untransformed N. benthamiana plants all developed wildtype symptoms characteristic for each virus. As expected, all
plants infected with the p19-expressing PVX vector, pHS142,
died by 3 wpi following necrosis and vascular collapse elicited
by expression of p19 (data not shown). From these experiments, we conclude that the transgenic DI plants were protected against TBSV necrosis and the deleterious effects of
related tombusviruses, but protection did not extend to TMV,
BDMV, and wild-type PVX, or PVX expressing TBSV p19
sequences.
DISCUSSION
We have analyzed 12 transgenic N. benthamiana lines that
express DI RNAs associated with TBSV infections. These lines
constituted a representative sample of 40 independent resistant lines recovered after transformation with the B10 DI RNA
sequence flanked by ribozymes. In vitro and in vivo results
demonstrated that accurate 59 and 39 processing occurred and
that the processed DI transcripts retained biological activity.
Negative controls with DI and ribozyme sequences in an antisense orientation (AS lines) or DI sequences flanked by extra
nucleotides at each end (ES lines) failed to exhibit biological
activity as assessed by the failure of the parental virus to amplify the transcripts or by an inability to protect against death
of infected plants. The results also demonstrated that the ribozyme-flanked DI transcripts were amplified rapidly following infection of transgenic protoplasts with the parental TBSV
strain and that infected transgenic plants developed an attenuated disease phenotype irrespective of the kind and amount
of input viral inoculum. Moreover, resistance to related tombusviruses (CNV, CymRSV, and CIRV), which support amplification of the DI sequences, and the lack of protection with
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a distantly related tombus-like virus (cucumber leaf spot virus),
and unrelated viruses (BDMV, TMV, PVX, and pHS-142, a
PVX vector expressing the p19 protein of TBSV) indicate that
the broad-spectrum protective effects require efficient amplification of the transgenic DI RNA. These results suggest that
the TBSV B10 DI RNA can provide a useful source of disease
resistance against several tombusviruses that cause serious
problems in crop plants.
Our study also extends the results of Kollar et al. (28), who
previously found a protective effect in plants transformed with
DI RNA sequences of CymRSV and noted that antisense
sequences failed to provide protection. However, there are
several notable differences in the results of the two studies. The
most striking difference is that our experiments indicate that
the B10 DI sequences require the presence of exact or nearly
exact 59 and 39 termini in order to replicate efficiently and to
provide a consistent protective effect. In contrast, the CymRSV
DI transcripts and its flanking sequences appear to be more
than a third larger than the DI RNA used for cloning. Based
on the cloning description provided by Kollar et al. (28), we
estimate that the nonviral sequences consisted of 76 nonviral
residues flanking the 59 terminus of the DI RNA and a large 39
terminal extension consisting of 19 nt of polylinker sequences
plus an undefined number of nopaline synthetase terminator
sequences adjacent to a heterologous poly(A) tail. However,
the size of the amplified hybridizing component was similar to
that of the native DI RNA, suggesting that at some stage
during CymRSV infection the extra sequences flanking the
transcribed DI RNA were eliminated to give rise to a native
protective DI RNA. Alternatively, the DI RNA could have
arisen de novo from the inoculum source or via recombination
between the transgene and the inoculated CymRSV. In this
regard, recombination events that yield defective RNAs have
been shown to occur in whole-plant infections without serial
passage, but amplification of defective RNAs was not detected
in protoplast experiments (29). Our experiments showed that
the processed DI RNAs accumulated to high abundance after
infection of transgenic protoplasts with TBSV. These results
thus provide strong evidence that the amplified DI RNAs were
derived directly from the low-abundance transgenic DI RNA
sequences, rather than from TBSV. Such experiments, unfortunately were not conducted by Kollar et al. (28); therefore
from the data presented, we are unable to directly compare the
time required to give rise to actively replicating DI RNA molecules or to assess the rates at which the CymRSV and TBSV
DI RNAs increase in abundance following infection of single
cells with the respective parental tombusviruses. Thus, although we have no ready explanation for the discrepancies
between these two studies, our results with B10 ES derivatives
do suggest that nonviral flanking sequences can inhibit DI
RNA replication and that these sequences can easily be eliminated by appropriate ribozyme processing.
The requirement for processing of the DI RNA and our
demonstration that amplification of the resulting RNA transcripts occurs upon infection of the transgenic plants with
TBSV and related viruses provides persuasive evidence that
protection requires biological activity of the recombinant DI
RNA. The initial high abundance of the DI RNA combined
with a subsequent reduction in the DI RNA levels at the later
stages of infection is typical of the events occurring during
wild-type DI RNA protection in untransformed plants (22, 25,
27, 52). The results are also in agreement with previous findings showing that infections containing DI RNAs exhibit substantial reductions in the accumulation of TBSV gRNA,
sgRNA 1, and sgRNA2 and in the levels of the p19- and
p22-encoded proteins (25, 52). These results thus are compat-

J. VIROL.

ible with a model whereby DI RNA-mediated modulation in
the symptom phenotype results from competition for available
replicase between the helper virus and the DI RNA molecules
(25). Milder necrosis due to reduction in accumulation of the
p19 protein and reduced spread of the virus as a consequence
of interference with synthesis of the p22 movement protein
may also contribute to the attenuated disease phenotype (52).
Therefore, the broad-spectrum protective effects observed in
the transgenic DI plants appear to involve very different mechanisms than those leading to specific resistance that normally is
restricted to viral isolates whose sequences are used for coat
protein or nontranslatable RNA-mediated resistance (1, 2).
Our results also indicate that DI RNA-mediated protection
differs fundamentally from the somewhat broader resistance
observed in plants transgenic for defective viral movement
proteins. In this regard, several studies have shown that plants
expressing mutated nonfunctional movement protein genes,
analogous to the TMV 30-kDa protein (8, 33) or dysfunctional
mutations within the triple gene block movement protein
genes (3, 54), exhibit resistance which possibly is mediated via
a dominant negative mechanism targeting cell-to-cell movement processes.
The present work demonstrates that DI RNAs have considerable potential for broad-spectrum control of the lethal disease syndrome elicited by TBSV and several other members of
the tombusvirus genus. Nevertheless, several questions relevant to the agronomic application of this strategy need to be
assessed in direct field tests. (i) Will DI RNA-mediated protection be durable under conditions of widespread distribution
of transgenic plants? (ii) Can detrimental effects result from
the use of DI RNAs as sources of disease resistance? (iii) What
are the prospects for application of the DI strategy to the vast
majority of viruses that fail to generate DI RNAs during the
normal course of replication? In response to the first question,
the DI RNA protective effects appear to rely to a considerable
extent on recognition of cis-acting 59- and 39-terminal sequences by the replicase of the invading virus. However, other
less obvious properties of the DI RNAs also affect symptom
attenuation, because we have observed that DI isolates from
the same source and from different viruses vary substantially in
their protective effects. In this regard, our strategy involving
analysis of protoplasts and whole plants for efficacy of DI RNA
before construction of transgenic plants provides a convenient
method to evaluate optimal levels of protection with various
derivatives against invasion by several different viruses. We
further propose that the protective effects will be quite durable
because protection relies on the ability of the DI RNAs to be
amplified by the invading virus. Since DI RNA amplification
requires recognition of cis-acting elements within the DI
RNAs, mutations to circumvent protection probably would
require fundamental replicase alterations to change the recognition specificity for essential cis elements, coupled with simultaneous mutations at the 59 and 39 termini of the gRNAs to
accommodate the new requirements for the mutated replicase.
Therefore, it is likely that the selection of virus mutants able to
circumvent protective effects of a particular DI transgene
would be negligible, even following widespread release of
transgenic varieties. Should such events occur, subsequent DI
RNAs generated from the mutant viruses could provide alternative sources of material for construction of second-generation transgenic plants. In addition, we could expect the DI
RNAs themselves to self-select to become competitive within
protected plants. In terms of environmental safety, the potential detrimental effects of the use of transgenes for crop protection have been discussed in numerous forums (7, 16, 26, 44,
56). We should stress that DI RNAs circumvent most of the
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problems envisioned for other sources of PDR, because with
only a few rare exceptions (19, 31, 42), DI RNAs attenuate
rather than exacerbate the disease phenotype. Moreover, DI
RNAs have been identified only in experiments with plant virus
infections and have not been shown to exist in nature (27).
However, even though transgenic DI RNAs should be able to
move to adjacent plants, experimental analyses suggest that
introduced DI RNAs do not persist in natural tombusvirus
populations (4). In addition, most tombusviruses are soilborne,
and inoculum appears to be replenished primarily from decaying plant material killed during infections. Since the protective
effects of the RzDI plants are very robust and reduce the levels
of virus following infection, a secondary benefit should be a
reduction of the available load of inoculum returned to the soil
upon death of infected plants.
In conclusion, we anticipate that field studies will demonstrate that transgenic plants relying on DI RNAs for broadspectrum protection against tombusvirus infections will exhibit
predictable disease attenuation, that the protective effects will
be durable, and that minimal, if any, adverse environmental
consequences will result from the widespread use of such
sources of resistance. The possible use of DI RNAs as sources
of protection against other viruses will need to be investigated
individually. However, the results of in vitro experiments reporting the serendipitous generation of artificial DI RNAs with
brome mosaic virus (34, 35) and barley stripe mosaic virus (62)
suggest that there is considerable potential for exploitation of
DI RNAs as sources of resistance, even with viruses that do not
normally generate DI RNAs de novo.
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